Literature DB >> 18254813

Poly-L-lactic acid: a perspective from my practice.

Neil S Sadick1.   

Abstract

Lipoatrophic sagging in the periorbital and cheek areas is a characteristic feature of the aging face. Soft tissue regeneration in these areas using a volumizer such as poly-l-lactic acid (PLLA) can help reduce the impact of these features. PLLA generates semipermanent correction, lasting for 2 years, and is a resorbable biocompatible device with a history of successful use in many clinical applications. This practice has administered many treatments of PLLA over the past 2 years with excellent results and with minimal complications. Minimization of adverse events and optimal cosmetic results are achieved when PLLA is diluted appropriately, injected in the proper plane and with posttreatment massage. The physician can fine-tune tissue volume correction with PLLA by spacing treatment sessions at least 4 to 6 weeks apart. Although approved for the correction of facial lipoatrophy in patients with human immunodeficiency virus, approval for the use of PLLA for cosmetic indications is currently pending.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18254813     DOI: 10.1111/j.1473-2165.2008.00362.x

Source DB:  PubMed          Journal:  J Cosmet Dermatol        ISSN: 1473-2130            Impact factor:   2.696


  4 in total

1.  Facial aesthetic correction with injectable poly-L-lactic Acid following removal of malar cheek implants.

Authors:  Cherie M Ditre
Journal:  J Clin Aesthet Dermatol       Date:  2009-06

Review 2.  Collagen Stimulators in Body Applications: A Review Focused on Poly-L-Lactic Acid (PLLA).

Authors:  Marie-Odile Christen
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-06-21

3.  Counseling patients on facial volume replacement and adherence with posttreatment instructions.

Authors:  Doris Day
Journal:  Patient Prefer Adherence       Date:  2010-09-07       Impact factor: 2.711

4.  Polylactide-Based Stent Coatings: Biodegradable Polymeric Coatings Capable of Maintaining Sustained Release of the Thrombolytic Enzyme Prourokinase.

Authors:  Alexander S Baikin; Alexey G Kolmakov; Lyudmila A Shatova; Elena O Nasakina; Mars G Sharapov; Ilya V Baymler; Sergey V Gudkov; Mikhail A Sevostyanov
Journal:  Materials (Basel)       Date:  2019-12-09       Impact factor: 3.623

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.